A new study led by The University of Texas at Arlington, University of California Los Angeles, University of Sherbrooke, and ...

Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term management of ...